AGM Chairman & CEO Address to Shareholders

• FY26 revenue increased by 15.5% to $10.8 billion
• Normalised EBIT rose by 20.6% to $1.09 billion
• Net debt of $663 million represented 0.57 times normalised EBITDA
• Sigma plans to open two stores in London before Christmas
• Sigma entered the UK market through a joint venture with Greenlight Pharmacy

Sigma Healthcare's Annual General Meeting (AGM) featured addresses from the Chairman and CEO, discussing the company's achievements in FY26. The company reported a 15.5% increase in revenue to $10.8 billion and a 20.6% rise in normalised EBIT to $1.09 billion. The net debt stood at $663 million, representing 0.57 times normalised EBITDA. Sigma expanded its global network, adding 20 stores internationally and 24 stores in Australia. The company also achieved $32 million in annualised synergy benefits. Sigma plans to open two stores in London before Christmas, entering the UK market through a joint venture with Greenlight Pharmacy. The AGM also discussed governance, ESG initiatives, and future growth strategies.

Sigma enters FY27 with stronger foundations, aiming to capture remaining integration benefits, sustain domestic momentum, and expand internationally in a measured way.